As regulators worldwide raise concerns about this once-popular ingredient, talc alternatives have taken their place. But they ...

Johnson & Johnson’s Q1 2025 earnings reveal growth in sales and EPS, boosted by MedTech and Pharma. Click for my updated look at JNJ and its most recent news.

The Dark Secrets of Johnson & Johnson” by Gardiner Harris scrutinizes the behavior and legacy of the company, as well as that ...

Johnson & Johnson has agreed to pay more than $100 million to settle over 1,000 lawsuits that allege the company’s Baby Powder talc products caused cancer, according to Bloomberg. Citing people ...

On Friday, Mad Money host Jim Cramer outlined what investors should focus on in the week, especially pointing to earnings ...

With recession concerns circulating in the market, Johnson & Johnson (JNJ) stock could stabilize many portfolios. Since its founding in ...

which has been battling class-action litigation claiming that its talc-based products like Johnson’s Baby Powder have caused cancer and has put a $6.5 billion settlement offer on the table ...

Goldman Sachs, JPMorgan and Morgan Stanley all saw huge jumps in trading revenue. The tariff fight is deepening Chinese consumers' preference for domestic goods.

The company continues to face litigation over its talc baby powder, taken off the market in 2023. Netflix Aims to Join the $1 Trillion Club The streaming service has shared financial performance ...

U.S. Bankruptcy Judge Christopher Lopez in Houston denied healthcare company Johnson & Johnson’s $10 billion proposal to end tens of thousands of lawsuits claiming that its baby powder and other talc ...